Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Immunogenicity Objective To evaluate the antibody response to each influenza vaccine antigen after vaccination with the TIVf vaccine, as measured by single radial hemolysis (SRH) or hemagglutination inhibition (HI) assay in accordance with Guidance CPMP/BWP/214/96 Safety Objective To evaluate the safety of TIVf in adult subjects in compliance with the requirements of the current European Union recommendations for clinical trials related to yearly licensing of influenza vaccines (CPMP/BWP/214/96)
Critère d'inclusion
- Prophylaxis of influenza